TONOPAN 0,5 mg / 40 mg /175 mg COMPRIMIDOS RECUBIERTOS España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

tonopan 0,5 mg / 40 mg /175 mg comprimidos recubiertos

mizar farmaceutica s.l. - dihidroergotamina mesilato; cafeina anhidra; propifenazona - comprimido - 0,5 mg/40 mg/175 mg - dihidroergotamina mesilato 0,5 mg; cafeina anhidra 40 mg; propifenazona 175 mg - dihidroergotamina, combinaciones con

Comirnaty Unión Europea - español - EMA (European Medicines Agency)

comirnaty

biontech manufacturing gmbh - single-stranded, 5’-capped messenger rna produced using a cell-free in vitro transcription from the corresponding dna templates, encoding the viral spike (s) protein of sars-cov-2 - covid-19 virus infection - vacunas - comirnaty 30 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older.  comirnaty 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty original/omicron ba. 1 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older who have previously received at least a primary vaccination course against covid-19. comirnaty original/omicron ba. 4-5 (15/15 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty original/omicron ba. 4-5 (5/5 micrograms)/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years.  comirnaty original/omicron ba. 4-5 (1. 5/1. 5 micrograms)/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years.  comirnaty omicron xbb. 5 30 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in individuals 12 years of age and older. comirnaty omicron xbb. 5 10 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 10 micrograms/dose dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in children aged 5 to 11 years. comirnaty omicron xbb. 5 3 micrograms/dose concentrate for dispersion for injection is indicated for active immunisation to prevent covid-19 caused by sars-cov-2, in infants and children aged 6 months to 4 years. el uso de esta vacuna debe estar en conformidad con las recomendaciones oficiales.

CDVAC CARBUNCLO Argentina - español - SANI (Asociación de Cooperativas Argentinas)

cdvac carbunclo

centro diagnóstico veterinario s.a. - cada ml de vacuna contiene un mínimo 9.000.000 de esporos acapsulados apatógenos de bacillus anthracis cepa sterne suspendidos en solución buffer glicerinada saponinada. - cada ml de vacuna contiene un mínimo 9.000.000 de esporos acapsulados apatógenos de bacillus anthracis cepa sterne suspendidos en solución buffer glicerinada saponinada. - vacuna anti carbunclo bacteridiano, compuesta por esporos de bacillus anthracis cepa sterne suspendidos en solución buffer glicerinada saponinada. - bovinos; equinos; ovinos; porcinos

KUFER Q-C POLVO POLVO PARA RECONSTITUIR Ecuador - español - Agencia Nacional de Regulación, Control y Vigilancia Sanitaria

kufer q-c polvo polvo para reconstituir

laboratorios biogenet scc [ec] ecuador - cada sobre de 3.875g de polvo contiene: extracto de leche de cardo mariano 125 mg (milk thistle extract) al 80% de silimariana. equiv. a 100 mg de silimarina acido ascirbico (vit. c) 1000 mg coenzima q 10 (ubidecarenona) 10 mg - polvo para reconstituir - cada sobre de 3.875g de polvo contiene: extracto de leche de cardo mariano 125 mg (milk thistle extract) al 80% de silimariana. equiv. a 100 mg de silimarina acido ascirbico (vit. c) 1000 mg coenzima q 10 (ubidecarenona) 10 mg

VACUNA CONTRA BRUCELOSIS BOVINA Argentina - español - SANI (Asociación de Cooperativas Argentinas)

vacuna contra brucelosis bovina

agrofarma interamericana s. c. p.a. - brucella abortus cepa 19 bacterina; solución fisiológica bufferada - brucella abortus cepa 19 bacterina ; solución fisiológica bufferada - inmunuzación contra la brucelosis. - bovinos

KUFER Q FORTE 140 mg CAPSULA Perú - español - DIGEMID (Dirección General de Medicamentos, Insumos y Drogas)

kufer q forte 140 mg capsula

drogueria laboratorios pharmex s.a.c. - silimarina; - capsula - por capsula; silimarina 140.000000 mg; - all other therapeutics products

KUFER Q FORTE CAPSULAS 140 mg Ecuador - español - Agencia Nacional de Regulación, Control y Vigilancia Sanitaria

kufer q forte capsulas 140 mg

laboratorios biogenet scc [ec] ecuador - silimarina 140.00 mg - capsulas - cada tableta contiene: silimarina 140.00 mg (en forma de silimarina al 80%=175 mg)

KUFER Q-CIRRO Ecuador - español - Agencia Nacional de Regulación, Control y Vigilancia Sanitaria

kufer q-cirro

laboratorios biogenet scc ecuador - l-ornitina- l-aspartato 3000,0 mg - polvo para reconstitucion oral - cada sobre de 6 g contiene: l-ornitina- l-aspartato 3000,0 mg